New multisociety guidance identifies menstrual irregularities as potential early markers of cardiovascular risk, extending prevention efforts into adolescence.
Patients with greater frailty showed larger improvements in health-related quality of life, while cardiovascular treatment effects did not differ significantly across frailty categories.